Methods
We tested a series of pyrazol compound structurally related to Pyr3 [1], a recently discovered TRPC3 inhibitor, for effects on receptor-as well as store-operated Ca 2+ entry into RBL-2H3 mast cells and HEK293 cells overexpressing TRPC3.
Results and conclusions
We identified novel Ca 2+ entry inhibitors, which are able to discriminate between the two tightly related pathways of receptor/second messenger-activated and store-operated calcium entry. These compounds appear suitable for selective modulation of Ca 2+ -dependent gene transcription in a variety of mammalian cells. 
